Your browser doesn't support javascript.
loading
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.
Romero, Joan Miguel; Titmuss, Emma; Wang, Yifan; Vafiadis, James; Pacis, Alain; Jang, Gun Ho; Zhang, Amy; Golesworthy, Bryn; Lenko, Tatiana; Williamson, Laura M; Grünwald, Barbara; O'Kane, Grainne M; Jones, Steven J M; Marra, Marco A; Wilson, Julie M; Gallinger, Steven; Laskin, Janessa; Zogopoulos, George.
Afiliación
  • Romero JM; Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Titmuss E; Rosalind and Morris Goodman Cancer Institute of McGill University, Montréal, QC, Canada.
  • Wang Y; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC, Canada.
  • Vafiadis J; Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Pacis A; Rosalind and Morris Goodman Cancer Institute of McGill University, Montréal, QC, Canada.
  • Jang GH; Department of Surgery, McGill University, Montréal, QC, Canada.
  • Zhang A; Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Golesworthy B; Rosalind and Morris Goodman Cancer Institute of McGill University, Montréal, QC, Canada.
  • Lenko T; Rosalind and Morris Goodman Cancer Institute of McGill University, Montréal, QC, Canada.
  • Williamson LM; Canadian Centre for Computational Genomics, McGill University and Genome Québec Innovation Centre, Montréal, QC, Canada.
  • Grünwald B; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • O'Kane GM; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Jones SJM; Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Marra MA; Rosalind and Morris Goodman Cancer Institute of McGill University, Montréal, QC, Canada.
  • Wilson JM; Research Institute of the McGill University Health Centre, Montréal, QC, Canada.
  • Gallinger S; Rosalind and Morris Goodman Cancer Institute of McGill University, Montréal, QC, Canada.
  • Laskin J; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC, Canada.
  • Zogopoulos G; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
NPJ Precis Oncol ; 7(1): 73, 2023 Aug 09.
Article en En | MEDLINE | ID: mdl-37558751
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Precis Oncol Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Precis Oncol Año: 2023 Tipo del documento: Article País de afiliación: Canadá